Skip to main content
1340714-AACR-2024-Microsite-Hero_Illum
Event

Revvity at AACR 2024

Empowering researchers to unlock possibilities in cancer research

The speed of innovation in cancer research has been extraordinary, with novel targeted treatments and immunotherapies showing real promise.

However, due to the evolving nature of the disease, therapy resistance remains a huge challenge. To attempt to overcome this challenge , a deep understanding of every tumor and its microenvironment is needed.

Our latest innovations help provide a holistic understanding of those resistance barriers, enabling the development of personalized combinational therapies. By gaining deep insights into disease, we empower you to advance your research toward breakthroughs.

Our shared history of innovation 

We have a deep-rooted history of helping you accelerate cancer research.

Today, our family of innovative products, including the IVIS ® Spectrum 2 system, Fontus™ liquid handling workstations, TotalSeq™ reagents powered by BioLegend®, Dharmacon gene modulation reagents, and the Pin-point™ Base Editing Platform , can provide you with the support needed to study different aspects of cancer, from genomics to precision medicine and beyond.

With our commitment to innovation, combined with our shared knowledge and expertise, we are here to help fast track your progress in cancer research.

For research use only. Not for use in diagnostic procedures.

 

revvityannualmeeting

BOOTH # 731

See our trusted brands

  • AlphaLISA®
  • BioLegend®
  • Cellometer®
  • Certimmune
  • Dharmacon
  • EnVision® Nexus
  • Fontus™
  • HTRF®
  • IVIS® Spectrum
  • Opera Phenix® Plus
  • Vega® Preclinical Ultrasound
  • VICTOR® Nivo

 

BL_logo 600x150
 

Featured Solutions

microsite
Experimental and molecular therapeutics

From discovery through manufacturing, creating safe and effective therapies is complex and expensive. Revvity enables scientists to develop and streamline workflows to help overcome these challenges.

From discovery through manufacturing, creating safe and effective therapies is complex and expensive. Revvity enables scientists to develop and streamline workflows to help overcome these challenges.

Base editing

Providing the Pin-point™ Base Editing Platform to offer unparalleled flexibility to "mix and match" individual system components, allowing full optimization of each targeted gene edit.

Pin-point™ Base Editing Platform

Cell counting & image cytometry

A fast and efficient way to assess cell health and viability, immunophenotyping, and perform a range of other routine cell-based assays.

Cell Counters & Image Cytometers
Cell Counting Reagents & Consumables 

In Vivo preclinical imaging

Whether you are monitoring tumor growth and progression, angiogenesis, metastases, performing drug efficacy and toxicology studies, or enhancing your understanding of cancer biology pathways, we have the tools to help with your next cancer discovery.

In Vivo Imaging Instruments
In Vivo Imaging Reagents
In Vivo Imaging Software

Cellular and humoral immunoassays

Accelerate your vaccine and immunotherapy programs and unlock advanced proprietary technology, platforms, and development services with Certimmune’s global immunology services

Global Immunology Services

Viral vector products

Lentiviral vectors have the ability to transduce both dividing and non-dividing cells which are used as general tools for basic research and translational applications.

Lentiviral Transduction Enhancer

GMP solutions

To ensure quality at every step of the bioprocessing workflow, we offer recombinant proteins, functional antibodies, and cell culture reagents produced under Good Manufacturing Practices (GMP) for ex vivo cell processing and downstream manufacturing.

Cell-Vive GMP Portfolio

cell-biology-microsite
Cellular biology & genetics

Understanding how and why tumors proliferate and evolve is critical for identifying molecular targets for therapeutic or preventive intervention. Our reagent platforms and services allow researchers to explore genetic and mechanistic processes with ease. 

Understanding how and why tumors proliferate and evolve is critical for identifying molecular targets for therapeutic or preventive intervention. Our reagent platforms and services allow researchers to explore genetic and mechanistic processes with ease. 

Microplate readers and microplates

A powerful and reliable plate reader to help accelerate your drug discovery and development by assisting in the identification of drug compounds and helping to advance it from discovery to development to manufacturing.

Multimode Plate Readers
Mini ELISA Plate Reader™
Microplates

Immunoassays 

In the race to the next big cancer breakthrough, you need to have the best tools available. We are constantly working to keep pace with the speed of your innovation to provide you with the products to help you in this discovery race.

New assays are available in Alpha SureFire® Ultra™, AlphaLISA®, and HTRF® technologies with the most recently released targets including BCL-2 Phospho S70 and Total, BCL-X Total, Ikaros Total, RAB12 Phospho S106, WDR5 Total, Wee1 Total, RAPTOR Total, p300 Total, CREBBP Total, HDAC5 Phospho S259 and Total, PLK1 Phospho T210 and Total, GSPT1

Newest Assay Kits

Microfluidic protein or DNA/RNA characterization

Simplify traditional gel separations while improving the reliability of your data with the LabChip® automated microfluidic capillary electrophoreses (micro-CE) technology which enables the analysis of genomic or protein samples in seconds.

Protein Characterization System
Microfluidic Nucleic Acid Analysis

Gene modulation

Supporting researchers on this journey at the DNA, RNA, and protein level with the broadest range of functional genomic tools including advanced gene modulation and gene editing solutions to help elucidate complex biological networks for functional genomic studies.

Dharmacon™ reagents

PreClinical services

Our goal is to empower you to detect and validate genetic and protein targets early in the development journey, unlocking predictive and prognostic insights for preclinical and clinical success.

OncoSignature™ Cell Panel Screening Service
Functional Genomic Screening Service
Immune Cell Screening Service

 

microsite-tumor
Tumor Biology Solutions

Analyzing a tumor’s composition, organization, functionality, and microenvironment enables you to find routes for therapeutic manipulation and identify predictive biomarkers. Discover how our imaging and single-cell sequencing solutions can help you make your discoveries faster.

Analyzing a tumor’s composition, organization, functionality, and microenvironment enables you to find routes for therapeutic manipulation and identify predictive biomarkers. Discover how our imaging and single-cell sequencing solutions can help you make your discoveries faster.

High-content imaging

Whether you are a basic researcher trying to better understand biological processes in cancer cells or investigating how drugs affect those processes, we have the tools  to assist you in advancing your cancer research and discovery.

High-Content Imaging Instruments
Cellular Imaging Reagents
Cellular Imaging Software
Microplates for Cell Imaging
Tissue Screening

Single-cell multiomics

Solutions for key steps of your single-cell sequencing journey — specifically designed to work alongside your existing processing steps, making implementation simpler.

Cell Isolation & Purification
Cell Counters & Image Cytometers
Multiomics Reagents
Multiomics Analysis Software

 

1340714 AACR 2024 Microsite Icons_ClinicalResearchSolutions
Clinical Research Solutions

Advances in genomic sequencing and bioinformatics have revealed the enormous potential of cancer genomics. Our next-generation sequencing (NGS) technology solutions can facilitate the achievement of rapid, accurate sequencing of tumor-driving mutations as well as identifying biomarkers of disease progression. 

Advances in genomic sequencing and bioinformatics have revealed the enormous potential of cancer genomics. Our next-generation sequencing (NGS) technology solutions can facilitate the achievement of rapid, accurate sequencing of tumor-driving mutations as well as identifying biomarkers of disease progression. 

Next-generation sequencing workflow

Our complete library prep workflows help laboratories to minimize bias and human errors, while increasing throughput and reducing hands-on time. Revvity provides solutions that can support you address the full breadth of your NGS requirements – all from a single-source workflow optimized and supported to help improve your productivity.

Sample Homogenization
Nucleic Acid Isolation
Liquid Handler Workstations
Library Preparation
Molecular Reference Standards
Walk-away Automation

Discover the automation of the Illumina TruSight Oncology 500 assay on the Revvity Fontus NGS Workstation.

Biomarker identification

We offer innovative, end-to-end workflows for biomarker identification and characterization as well as applications that enable labs to translate insights into decisions rapidly and efficiently.

ctDNA
Exosome/cfRNA


Posters

 

Microfluidic Capillary Electrophoresis Optimization of high throughput cfDNA and pDNA measurements for enabling Cancer Diagnostics and Gene Therapy Development
  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Clinical Research
  • Session Title: Circulating Nucleic Acids 4
  • Location: Poster Section 40
  • Poster Board Number: 13
  • Abstract Presentation Number: 5026

See the full abstract

  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Clinical Research
  • Session Title: Circulating Nucleic Acids 4
  • Location: Poster Section 40
  • Poster Board Number: 13
  • Abstract Presentation Number: 5026

See the full abstract

Alternative cell counting and viability detection using NexGreen/PI fluorescent stain on multiple low- and high-throughput image cytometry platforms
  • Session Date and Time: Monday Apr 8, 2024 1:30 PM - 5:00 PM
  • Session Category: Chemistry
  • Session Title: High-Throughput Screening and New Assay Technology
  • Location: Poster Section 20
  • Poster Board Number: 14
  • Abstract Presentation Number: 3103

See the full abstract

  • Session Date and Time: Monday Apr 8, 2024 1:30 PM - 5:00 PM
  • Session Category: Chemistry
  • Session Title: High-Throughput Screening and New Assay Technology
  • Location: Poster Section 20
  • Poster Board Number: 14
  • Abstract Presentation Number: 3103

See the full abstract

Developing a multiplex assay to monitor apoptosis and necrosis using the Cellaca® PLX Image Cytometer
  • Session Date and Time: Sunday Apr 7, 2024 1:30 PM - 5:00 PM
  • Session Category: Molecular/Cellular Biology and Genetics
  • Session Title: Apoptosis and FerroptosisLocation: Poster Section 15
  • Poster Board Number: 12
  • Abstract Presentation Number: 356

See the full abstract

  • Session Date and Time: Sunday Apr 7, 2024 1:30 PM - 5:00 PM
  • Session Category: Molecular/Cellular Biology and Genetics
  • Session Title: Apoptosis and FerroptosisLocation: Poster Section 15
  • Poster Board Number: 12
  • Abstract Presentation Number: 356

See the full abstract

Characterization and comparison of hypoxia inducing factors on tumor growth and metastasis in 2D and 3D tumor models
  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: Models to Study Immune Cells in the Tumor Microenvironment
  • Location: Poster Section 10
  • Poster Board Number: 23
  • Abstract Presentation Number: 4221

See the full abstract

  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: Models to Study Immune Cells in the Tumor Microenvironment
  • Location: Poster Section 10
  • Poster Board Number: 23
  • Abstract Presentation Number: 4221

See the full abstract

Measuring apoptotic effects of EP4A1 and EP4A2 on Kuramochi with a high-throughput multiplex image cytometric method
  • Session Date and Time: Monday Apr 8, 2024 1:30 PM - 5:00 PM
  • Session Category: Experimental and Molecular Therapeutics
  • Session Title: Novel Antitumor Agents 4
  • Location: Poster Section 26
  • Poster Board Number: 11
  • Abstract Presentation Number: 5930

See the full abstract

  • Session Date and Time: Monday Apr 8, 2024 1:30 PM - 5:00 PM
  • Session Category: Experimental and Molecular Therapeutics
  • Session Title: Novel Antitumor Agents 4
  • Location: Poster Section 26
  • Poster Board Number: 11
  • Abstract Presentation Number: 5930

See the full abstract

Feasibility of a novel image guided injection tool for non-surgical implantation of orthotopic tumors
  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: Detection, Treatment, and Prevention of Metastasis
  • Location: Poster Section 7
  • Poster Board Number: 19
  • Abstract Presentation Number: 4137

See the full abstract

  • Session Date and Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: Detection, Treatment, and Prevention of Metastasis
  • Location: Poster Section 7
  • Poster Board Number: 19
  • Abstract Presentation Number: 4137

See the full abstract

A prototype for a machine-learning assisted image analysis tool for preclinical in vivo studies
  • Session Date and Time: Monday Apr 8, 2024 9:00 AM - 12:30 PM
  • Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
  • Session Title: New Algorithms, Software, and Models
  • Location: Poster Section 37
  • Poster Board Number: 14
  • Abstract Presentation Number: 2336

See the full abstract

  • Session Date and Time: Monday Apr 8, 2024 9:00 AM - 12:30 PM
  • Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
  • Session Title: New Algorithms, Software, and Models
  • Location: Poster Section 37
  • Poster Board Number: 14
  • Abstract Presentation Number: 2336

See the full abstract

Noninvasive measurement of murine glioblastoma in vivo with a benchtop ultrasound instrument
  • Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: In Vivo Imaging and Anatomical and Molecular Pathology
  • Location: Poster Section 8
  • Poster Board Number: 14
  • Abstract Presentation Number: 4159

See the full abstract

  • Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: In Vivo Imaging and Anatomical and Molecular Pathology
  • Location: Poster Section 8
  • Poster Board Number: 14
  • Abstract Presentation Number: 4159

See the full abstract

High-throughput in vivo monitoring of splenomegaly and tumor burden in a murine breast cancer model
  • Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: In Vivo Imaging and Anatomical and Humanized Models
  • Location: Poster Section 9
  • Poster Board Number: 1
  • Abstract Presentation Number: 4177

See the full abstract

  • Time: Tuesday Apr 9, 2024 9:00 AM - 12:30 PM
  • Session Category: Tumor Biology
  • Session Title: In Vivo Imaging and Anatomical and Humanized Models
  • Location: Poster Section 9
  • Poster Board Number: 1
  • Abstract Presentation Number: 4177

See the full abstract